US FDA approves Novo Nordisk's Ozempic to cut risk of diabetic kidney disease progression
The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as death due to heart problems in diabetes patients with chronic kidney disease (CKD),
Novo’s Ozempic Gains US Nod for Kidney Disease, Widening Use
Novo Nordisk A/S’s blockbuster Ozempic won US approval to treat chronic kidney disease in patients who also have type 2 diabetes, further expanding the popular drug’s use.
US FDA approves Novo Nordisk's Ozempic to reduce risk of kidney diseases in diabetic patients
Breakthrough in diabetes treatment! The US FDA approves Ozempic for reducing kidney disease risk in diabetic patients. Learn more about this game-changing medication.
FDA approves Ozempic to help reduce risk of worsening chronic kidney disease
The FDA’s approval of Ozempic to battle chronic kidney disease “allows us to more broadly address conditions within cardiovascular-kidney-metabolic syndrome, which affects millions of
Doctors Can Now Prescribe Ozempic to Reduce Kidney Disease Risks in Diabetes Patients
Fact checked by Jillian Dara The Food and Drug Administration (FDA) on Tuesday approved Ozempic (semaglutide) to reduce the risk of complications and death in adults with both type 2 diabetes and chronic kidney disease.
FDA approves Ozempic to treat kidney disease in diabetes patients
The FDA approved Ozempic to treat kidney disease in Type 2 diabetes patients after trials showed it reduces the risk of disease progression, Novo Nordisk announced.
Ozempic-Like Drugs May Hold Risks For Surgical Patients, Officials Say
Surgical patients may still have leftovers in their system even after a standard fast, potentially increasing the chance of a serious complication.
CNN2d
FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients
Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the US Food and Drug Administration to reduce certain risks associated with ...
Arizona Daily Star1d
Ozempic vs. Semaglutide: 10 Weight Loss Medications Compared for 2025
Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ingredient, they are approved for different purposes. Ozempic is ...
Feds add Wegovy, Ozempic to list of drugs planned for Medicare price negotiations
Wegovy, Ozempic added to list of drugs where the federal government will try winning discounts from manufacturers.
USA Today9d
Taking Ozempic for weight loss? You might find other benefits, too - and a few risks
You may take Ozempic or another drug to control your diabetes ... This story was updated to add new information.
New York Post3d
Skinny ‘Ozempic’ phones are making a comeback: ‘A nostalgic twist’
Cellphones are taking a shot at slenderizing. It seems nothing is immune to society’s recent lean toward the extremely lean look — and smartphones are no exception to the voguish new rule ...
Psychology Today4d
Nature’s Ozempic
Ozempic and Wegovy mimic the effect of GLP-1 ... Plain white dough doesn’t get many takers, but poke a hole in it and add icing and you have a $10 billion donut industry. So sure, put sugar ...